24.05.2024 16:06:22

Lilly Increases Investment In Indiana-Based Unit To Enhance Production Of Zepbound, Mounjaro

(RTTNews) - Eli Lilly and Co. (LLY), Friday announced the decision to increase investment in Lebanon, Indiana manufacturing facility from $3.7 billion to $9 billion to enhance production of Zepbound and Mounjaro injections used for the treatment of obesity and type-2 diabetes, respectively.

Through the investment, Lilly expects to create an additional 200 full-time jobs and more than 5,000 construction jobs during the site's development.

Additionally, the company is planning to expand across new locations such as Research Triangle Park and Concord, North Carolina; Limerick, Ireland; and Alzey, Germany.

Currently, Lilly's stock is moving down 0.05 percent, to $808.02 on the New York Stock Exchange.

Analysen zu Eli Lillymehr Analysen

31.10.24 Eli Lilly Buy Jefferies & Company Inc.
13.02.24 Eli Lilly Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Eli Lilly 745,50 -0,09% Eli Lilly